48 results on '"Barsky, Andrew R."'
Search Results
2. Tubarial salivary gland sparing with proton therapy
3. Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery
4. Comparative Analysis of 5-Year Clinical Outcomes and Patterns of Failure of Proton Beam Therapy Versus Intensity Modulated Radiation therapy for Prostate Cancer in the Postoperative Setting
5. Disease-Related Outcomes and Toxicities of Intensity Modulated Radiation Therapy After Lung-Sparing Pleurectomy for Malignant Pleural Mesothelioma: A Systematic Review
6. Gender-based Disparities in Receipt of Care and Survival in Malignant Pleural Mesothelioma
7. Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma
8. Impact of Detecting Occult Pathologic Nodal Disease During Resection for Malignant Pleural Mesothelioma
9. Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer
10. 18F-Fluciclovine PET/CT in Therapeutic Decision Making for Prostate Cancer: A Large Single-Center Practice-Based Analysis
11. 18F-Fluciclovine Uptake in Acute Appendicitis
12. Case-Matched Outcomes of Proton Beam and Intensity-Modulated Radiation Therapy for Localized Prostate Cancer
13. Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation?
14. Safety of cyclin-dependent kinase4/6 inhibitor combined with palliative radiotherapy in patients with metastatic breast cancer
15. Dosimetric Results for Adjuvant Proton Radiation Therapy of HPV-Associated Oropharynx Cancer
16. Long-term Clinical Outcomes in Favorable Risk Prostate Cancer Patients Receiving Proton Beam Therapy
17. Abstract 661: Robust feature selection and ComBat-based harmonization to improve survival prediction in stage III lung cancer using radiomic phenotypes
18. Managing oligoprogressive malignant pleural mesothelioma with stereotactic body radiation therapy
19. Proton-Beam Therapy: At the Heart of Cardiac Dose-Sparing in Mediastinal Radiotherapy for Thymic Carcinoma
20. The efficacy and safety of definitive concurrent chemoradiotherapy for non‐operable esophageal cancer
21. 18F-Fluciclovine PET/CT in Therapeutic Decision Making for Prostate Cancer
22. Quantitation and predictors of short-term mortality following extrapleural pneumonectomy, pleurectomy/decortication, and nonoperative management for malignant pleural mesothelioma
23. Initial Clinical Experience Treating Patients With Lung Cancer on a 6MV-Flattening-Filter-Free O-Ring Linear Accelerator
24. Initial clinical experience treating patients with palliative radiotherapy for malignant pleural mesothelioma on the HalcyonTM linear accelerator
25. Initial Clinical Experience Treating Patients With Gynecologic Cancers on a 6MV Flattening Filter Free O-Ring Linear Accelerator
26. Posterior Intercostal Lymph Nodes Double Recurrence and Death Risk in Malignant Pleural Mesothelioma
27. Initial clinical outcomes for prostate cancer patients undergoing adjuvant or salvage proton therapy after radical prostatectomy
28. CLO20-030: Sex-Based Disparities in Receipt of Care and Survival in Malignant Pleural Mesothelioma
29. Investigating association of perineural invasion on prostate biopsy with Gleason score upgrading at prostatectomy: A multi‐institutional analysis
30. Non-prostate cancer malignancies detected by 18F-Fluciclovine PET/CT.
31. Proton beam re-irradiation for gastrointestinal malignancies: a systematic review
32. Increase in Superficial Dose in Whole-Breast Irradiation With Halcyon Straight-Through Linac Compared With Traditional C-arm Linac With Flattening Filter: In vivo Dosimetry and Planning Study
33. Proton beam therapy after radical prostatectomy
34. Initial Clinical Experience Treating Patients with Breast Cancer on a 6-MV Flattening-Filter-Free O-Ring Linear Accelerator
35. Comparative toxicity outcomes of proton‐beam therapy versus intensity‐modulated radiotherapy for prostate cancer in the postoperative setting
36. The efficacy and safety of hypofractionated radiotherapy with concurrent anti‐HER‐2 therapy following breast‐conserving therapy for breast cancer
37. Spine SBRT With Halcyon™: Plan Quality, Modulation Complexity, Delivery Accuracy, and Speed
38. Initial Clinical Experience Treating Patients with Breast Cancer on the Halcyon Linear Accelerator
39. First-ever Abscopal Effect after Palliative Radiotherapy and Immuno-gene Therapy for Malignant Pleural Mesothelioma
40. Extended Pleurectomy-Decortication–Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years
41. P04 - The Efficacy and Safety of Hypofractionated Radiotherapy with Concurrent anti-HER-2 Therapy Following Breast-conserving Therapy for Breast Cancer
42. P02 - Initial Clinical Experience Treating Patients with Breast Cancer on the Halcyon Linear Accelerator
43. Autistic trait interactions underlie sex-dependent facial recognition abilities in the normal population
44. Proton beam therapy after radical prostatectomy.
45. Radiomic features predict local failure-free survival in stage III NSCLC adenocarcinoma treated with chemoradiation.
46. Radiomic features predict local failure-free survival in stage III NSCLC adenocarcinoma treated with chemoradiation
47. Radiomic Phenotypes for Improving Early Prediction of Survival in Stage III Non-Small Cell Lung Cancer Adenocarcinoma after Chemoradiation.
48. Increase in Superficial Dose in Whole-Breast Irradiation With Halcyon Straight-Through Linac Compared With Traditional C-arm Linac With Flattening Filter: In vivo Dosimetry and Planning Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.